|
Three components to this case definition: |
|
(1) Antecedent requirements (both of the following requirements must be met): |
|
(1) Diagnosis of TB | Made before starting of combination antiretroviral therapy (CART) and should fulfill WHO criteria |
(2) Initial response to TB treatment | The patient’s condition should have stabilized or improved on appropriate TB treatment before CART initiation |
|
(2) Clinical criteria | |
|
The onset of TB-associated IRIS manifestations should be within 3 months of CART initiation, reinitiation, or regimen change because of treatment failure |
|
Of the following, at least one major criterion or two minor clinical criteria are required: |
|
Major criteria |
|
| New or enlarging lymph nodes, cold abscesses, or other tissue involvement |
| New or worsening radiological features of TB |
| New or worsening central nervous system CNS TB |
| New or worsening serositis |
|
Minor criteria |
|
| New or worsening constitutional symptoms such as fever, night sweats, or weight loss |
| New or worsening respiratory symptoms as cough, dyspnea, or stridor |
| New or worsening abdominal pain accompanied by peritonitis, hepatomegaly, splenomegaly, or abdominal adenopathy |
|
(3) Excluded alternative explanations for clinical deterioration |
|
| Failure of TB treatment because of TB drug resistance |
| Poor adherence to TB treatment |
| Another opportunistic infection or neoplasm |
| Drug toxicity or reaction |
|